Cited by 303Antifungal resistance and susceptibilityImmunodeficiency and Autoimmune DisordersNeutropenia and Cancer Infections

The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.

Factors Associated with Mortality in Transplant Patients with Invasive Aspergillosis

Open access

Baddley, John W., Andes, David R., Marr, Kieren A., Kontoyiannis, Dimitrios P., Alexander, Barbara D., Kauffman, Carol A., Oster, Robert A., Anaissie, Elias J., Walsh, Thomas J., Schuster, Mindy G., Wingard, John R., Patterson, Thomas F., Ito, James I., Williams, O. Dale, Chiller, Tom, Pappas, Peter G.·2010·Clinical Infectious Diseases

DOI 10.1086/652768PMC PMC2874071

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND: Invasive aspergillosis (IA) is an important cause of morbidity and mortality in hematopoietic stem cell transplant (HSCT) and solid organ transplant (SOT) recipients. The purpose of this study was to evaluate factors associated with mortality in transplant patients with IA. METHODS: Transplant patients from 23 US centers were enrolled from March 2001 to October 2005 as part of the Transplant Associated Infection Surveillance Network. IA cases were identified prospectively in this cohort through March 2006, and data were collected. Factors associated with 12-week all-cause mortality were determined by logistic regression analysis and Cox proportional hazards regression. RESULTS: Six-hundred forty-two cases of proven or probable IA were evaluated, of which 317 (49.4%) died by the study endpoint. All-cause mortality was greater in HSCT patients (239 [57.5%] of 415) than in SOT patients (78 [34.4%] of 227; P<.001). Independent poor prognostic factors in HSCT patients were neutropenia, renal insufficiency, hepatic insufficiency, early-onset IA, proven IA, and methylprednisolone use. In contrast, white race was associated with decreased risk of death. Among SOT patients, hepatic insufficiency, malnutrition, and central nervous system disease were poor prognostic indicators, whereas prednisone use was associated with decreased risk of death. Among HSCT or SOT patients who received antifungal therapy, use of an amphotericin B preparation as part of initial therapy was associated with increased risk of death. CONCLUSIONS: There are multiple variables associated with survival in transplant patients with IA. Understanding these prognostic factors may assist in the development of treatment algorithms and clinical trials.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1086/652768

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis
Herbrecht, R., Denning, D. W., Patterson, T. F., Bennett, J. E., Greene, R. E., Oestmann, J.-W., Kern, W. V., Marr, K. A., Ribaud, P., Lortholary, O., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020191 · Cited by 3,304
Self-citation
Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America
Walsh, T. J., Anaissie, E. J., Denning, D. W., Herbrecht, R., Kontoyiannis, D. P., Marr, K. A., Morrison, V. A., Segal, B. H., Steinbach, W. J., Stevens, D. A., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/525258 · Cited by 2,705
Self-citation
Defining Opportunistic Invasive Fungal Infections in Immunocompromised Patients with Cancer and Hematopoietic Stem Cell Transplants: An International Consensus
Aşçıoğlu, S., Rex, J. H., de Pauw, B., Bennett, J. E., Billé, J., Crokaert, F., Denning, D. W., Donnelly, J. P., Edwards, J. E., Erjavec, Z., et al. (2002) · Clinical Infectious Diseases · doi:10.1086/323335 · Cited by 2,315
Self-citation
Epidemiology and Outcome of Mould Infections in Hematopoietic Stem Cell Transplant Recipients
Marr, K. A., Carter, R. A., Crippa, F., Wald, A., & Corey, L. (2002) · Clinical Infectious Diseases · doi:10.1086/339202 · Cited by 1,446
Self-citation
Diagnosis of Invasive Aspergillosis Using a Galactomannan Assay: A Meta-Analysis
Pfeiffer, C. D., Fine, J. P., & Safdar, N. (2006) · Clinical Infectious Diseases · doi:10.1086/503427 · Cited by 964
Untitled work
(2006) · PubMed · Cited by 906
Treatment of Invasive Aspergillosis with Posaconazole in Patients Who Are Refractory to or Intolerant of Conventional Therapy: An Externally Controlled Trial
Walsh, T. J., RAAD, I. I., Patterson, T. F., Chandrasekar, P. H., Donowitz, G. R., Graybill, R. J., Greene, R. E., Hachem, R. Y., Hadley, S., Herbrecht, R., et al. (2006) · Clinical Infectious Diseases · doi:10.1086/508774 · Cited by 749
Self-citation
Liposomal Amphotericin B as Initial Therapy for Invasive Mold Infection: A Randomized Trial Comparing a High-Loading Dose Regimen with Standard Dosing (AmBiLoad Trial)
Cornely, O. A., Maertens, J. A., Bresnik, M., Ebrahimi, R., Ullmann, A. J., Bouza, E., Heußel, C. P., Lortholary, O., Rieger, C. T., Boehme, A., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/514341 · Cited by 744
Epidemiology of Aspergillus Infections in a Large Cohort of Patients Undergoing Bone Marrow Transplantation
Wald, A., Leisenring, W., van Burik, J., & Bowden, R. A. (1997) · The Journal of Infectious Diseases · doi:10.1086/516480 · Cited by 742
Combination Antifungal Therapy for Invasive Aspergillosis
Marr, K. A., Boeckh, M., Carter, R. A., Kim, H. W., & Corey, L. (2004) · Clinical Infectious Diseases · doi:10.1086/423380 · Cited by 607
Self-citation
Imaging Findings in Acute Invasive Pulmonary Aspergillosis: Clinical Significance of the Halo Sign
Greene, R. E., Schlamm, H. T., Oestmann, J. W., Stark, P., Durand, C. M., Lortholary, O., Wingard, J. R., Herbrecht, R., Ribaud, P., Patterson, T. F., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/509917 · Cited by 589
Self-citation
Invasive Aspergillosis following Hematopoietic Cell Transplantation: Outcomes and Prognostic Factors Associated with Mortality
Upton, A., Kirby, K. A., Carpenter, P. A., Boeckh, M., & Marr, K. A. (2007) · Clinical Infectious Diseases · doi:10.1086/510592 · Cited by 510
Self-citation
Defining Responses to Therapy and Study Outcomes in Clinical Trials of Invasive Fungal Diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer Consensus Criteria
Segal, B. H., Herbrecht, R., Stevens, D. A., Ostrosky-Zeichner, L. L., Sobel, J. D., Viscoli, C., Walsh, T. J., Maertens, J. A., Patterson, T. F., Perfect, J. R., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/590566 · Cited by 473
Self-citation
Fungal Infections in Recipients of Hematopoietic Stem Cell Transplants: Results of the SEIFEM B-2004 Study--Sorveglianza Epidemiologica Infezioni Fungine Nelle Emopatie Maligne
Pagano, L., Caira, M., Nosari, A., Lint, M. T. V., Candoni, A., Offidani, M., Aloisi, T., Irrera, G., Bonini, A., Picardi, M., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/522189 · Cited by 413
Incidence of invasive aspergillosis following hematopoietic stem cell and solid organ transplantation: interim results of a prospective multicenter surveillance program
Morgan, J., Wannemuehler, K. A., Marr, K. A., Hadley, S., Kontoyiannis, D. P., Walsh, T. J., Fridkin, S. K., Pappas, P. G., & Warnock, D. W. (2005) · Medical Mycology · doi:10.1080/13693780400020113 · Cited by 407
Self-citation
Invasive Aspergillosis: Epidemiology, Diagnosis and Management in Immunocompromised Patients
Maschmeyer, G., Haas, A., & Cornely, O. A. (2007) · Drugs · doi:10.2165/00003495-200767110-00004 · Cited by 366
Factors Associated with Overall and Attributable Mortality in Invasive Aspergillosis
Nivoix, Y., Velten, M., Letscher‐Bru, V., Moghaddam, A. Z., Natarajan‐Amé, S., Fohrer, C., Lioure, B., Bilger, K., Lutun, P., Marcellin, L., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/592255 · Cited by 340
Combination of Voriconazole and Caspofungin as Primary Therapy for Invasive Aspergillosis in Solid Organ Transplant Recipients: A Prospective, Multicenter, Observational Study
Singh, N., Limaye, A. P., Forrest, G. N., Safdar, N., oz, P. M., Pursell, K. J., Houston, S. H., Rosso, F., Montoya, J. G., Patton, P. R., et al. (2006) · Transplantation · doi:10.1097/01.tp.0000202421.94822.f7 · Cited by 336
Self-citation
Efficacy and toxicity of caspofungin in combination with liposomal amphotericin B as primary or salvage treatment of invasive aspergillosis in patients with hematologic malignancies
Kontoyiannis, D. P., Hachem, R. Y., Lewis, R. E., Rivero, G., Torres, H. A., Thornby, J. A., Champlin, R., Kantarjian, H. M., Bodey, G. P., & RAAD, I. I. (2003) · Cancer · doi:10.1002/cncr.11479 · Cited by 287
Self-citation
Survival and Prognostic Factors of Invasive Aspergillosis After Allogeneic Bone Marrow Transplantation
Ribaud, P., Chastang, C., Latgé, J., Baffroy‐Lafitte, L., Parquet, N., Espéton, A. D. H., Sélimi, F., Rocha, V., Derouin, F., Socié, G., et al. (1999) · Clinical Infectious Diseases · doi:10.1086/515116 · Cited by 233
Aspergillus infection in lung transplant patients: incidence and prognosis
Iversen, M., Burton, C. M., Vand, S., Skovfoged, L., Carlsen, J., Milman, N. T., Andersen, C. B., Rasmussen, M., & Tvede, M. (2007) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-007-0376-3 · Cited by 148
Antifungal Combination Therapy
Baddley, J. W., & Pappas, P. G. (2005) · Drugs · doi:10.2165/00003495-200565110-00002 · Cited by 119
Self-citation
Prognostic Factors for Death Due to Invasive Aspergillosis after Hematopoietic Stem Cell Transplantation: A 1-Year Retrospective Study of Consecutive Patients at French Transplantation Centers
Cordonnier, C., Ribaud, P., Herbrecht, R., Milpied, N. J., Valteau‐Couanet, D., Morgan, C., Wade, A., & Cellulaire, S. F. D. G. D. M. E. D. T. (2006) · Clinical Infectious Diseases · doi:10.1086/500934 · Cited by 113
Overall survival and fungal infection-related mortality in patients with invasive fungal infection and neutropenia after myelosuppressive chemotherapy in a tertiary care centre from 1995 to 2006
Hahn‐Ast, C., Glasmacher, A. G., Mückter, S., Schmitz, A., Kraemer, A., Marklein, G., Brossart, P., & von Lilienfeld‐Toal, M. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp507 · Cited by 104
Changes in causes of death over time after treatment for invasive aspergillosis
Wingard, J. R., Ribaud, P., Schlamm, H. T., & Herbrecht, R. (2008) · Cancer · doi:10.1002/cncr.23441 · Cited by 89
Self-citation
Predicting survival in adults with invasive aspergillosis during therapy for hematological malignancies or after hematopoietic stem cell transplantation: Single‐center analysis and validation of the Seattle, French, and Strasbourg prognostic indexes
Parody, R., Martino, R., Sánchez, F., Subirá, M., Hidalgo, A., & Sierra, J. (2009) · American Journal of Hematology · doi:10.1002/ajh.21488 · Cited by 49
Estimating severe coccidioidomycosis in California
Flaherman, V. J., Hector, R., & Rutherford, G. W. (2007) · Emerging Infectious Diseases · doi:10.3201/eid1307.061480 · Cited by 44
VORICONAZOLE VERSUS AMPHOTERICIN B FOR PRIMARY THERAPY OF INVASIVE ASPERGILLOSIS
&NA; (2002) · Infectious Diseases in Clinical Practice · doi:10.1097/00019048-200205000-00033 · Cited by 35
Risk factors and attributable mortality of late aspergillosis after T‐cell depleted hematopoietic stem cell transplantation
Mihu, C. N., King, E., Yossepovitch, O., Taur, Y., Jakubowski, A. A., Pamer, E. G., & Papanicolaou, G. A. (2007) · Transplant Infectious Disease · doi:10.1111/j.1399-3062.2007.00272.x · Cited by 31
Combination Antifungal Therapy for Invasive Aspergillosis
Cesaro, S., & Visintin, G. (2005) · Clinical Infectious Diseases · doi:10.1086/428674 · Cited by 25
Combination of Voriconazole and Caspofungin as Primary Therapy for Invasive Aspergillosis in Solid Organ Transplant Recipients: A Prospective, Multicenter, Observational Study
Pruett, T. L. (2007) · Yearbook of Surgery · doi:10.1016/s0090-3671(08)70103-4 · Cited by 7
449: Aspergillus infection in lung transplant patients: Incidence and prognosis
Iversen, M., Burton, C. M., Vand, S., Skovfoged, L., Milman, N. T., Carlsen, J., & Rasmussen, M. (2007) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2006.11.471 · Cited by 4

Flagged first, then by citations

Sorted by citations

Global and Multi-National Prevalence of Fungal Diseases-Estimate Precision
Bongomin, F., Gago, S., Oladele, R., & Denning, D. (2017) · Journal of Fungi · doi:10.3390/jof3040057 · Cited by 2,953
“The global incidence of invasive aspergillosis was previously reported to be 200,000 cases with an associated mortality ranging from 30–80% [108], recently updated to >300,000 cases [20].”
Background
Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline
Ullmann, A. J., Aguado, J. M., Arikan-Akdagli, S., Denning, D. W., Groll, A. H., Lagrou, K., Lass-Flörl, C., Lewis, R. E., Munoz, P., Verweij, P. E., et al. (2018) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2018.01.002 · Cited by 1,556
Epidemiology of invasive aspergillosis in critically ill patients: clinical presentation, underlying conditions, and outcomes
Taccone, F. S., den Abeele, A. V., Bulpa, P., Misset, B., Meersseman, W., Cardoso, T., Paiva, J.-A., Blasco-Navalpotro, M. Á., Laere, E. D., Dimοpoulos, G., et al. (2015) · Critical Care · doi:10.1186/s13054-014-0722-7 · Cited by 409
Molecular and Nonmolecular Diagnostic Methods for Invasive Fungal Infections
Arvanitis, M., Anagnostou, T., Fuchs, B. B., Caliendo, A. M., & Mylonakis, E. E. (2014) · Clinical Microbiology Reviews · doi:10.1128/cmr.00091-13 · Cited by 367
Clinical epidemiology of 960 patients with invasive aspergillosis from the PATH Alliance registry
Steinbach, W. J., Marr, K. A., Anaissie, E. J., Azie, N. E., Quan, S.-P., Meier‐Kriesche, H., Apewokin, S. K., & Horn, D. L. (2012) · Journal of Infection · doi:10.1016/j.jinf.2012.08.003 · Cited by 347
Self-citation

See all 303

Authors: Baddley, J. W., Andes, D. R., Marr, K. A., Kontoyiannis, D. P., Alexander, B. D., Kauffman, C. A., Oster, R. A., Anaissie, E. J., Walsh, T. J., Schuster, M. G., Wingard, J. R., Patterson, T. F., Ito, J. I., Williams, O. D., Chiller, T., & Pappas, P. G.
Affiliations: University of Alabama (US)
University of Wisconsin–Madison (US)
Johns Hopkins University (US)
The University of Texas MD Anderson Cancer Center (US)
Duke University (US)
University of Michigan (US)
University of Arkansas at Little Rock (US)
National Institutes of Health (US)
University of Pennsylvania (US)
University of Florida (US)
The University of Texas at San Antonio Health Science Center (US)
City Of Hope National Medical Center (US)
Centers for Disease Control and Prevention (US)
Corresponding author: Baddley, John W.
ORCID: Baddley, John W.
Andes, David R.
Marr, Kieren A.
Kontoyiannis, Dimitrios P.
Alexander, Barbara D.
Oster, Robert A.
Walsh, Thomas J.
Schuster, Mindy G.
Wingard, John R.
Patterson, Thomas F.
Chiller, Tom
Pappas, Peter G.
Venue: Clinical Infectious Diseases
Publisher: Oxford University Press (OUP)
Published: 2010-06-15
Volume: 50
Issue: 12
Pages: 1559-1567
ISSN: 1058-4838 (ISSN-L)
1537-6591
DOI: 10.1086/652768
PMC: PMC2874071
OpenAlex: W2133167433
Cited by: 303
References: 32
Citations by year: 2026: 7 · 2025: 14 · 2024: 13 · 2023: 13 · 2022: 14 · 2021: 13 · 2020: 17 · 2019: 16 · 2018: 10 · 2017: 29 · 2016: 30 · 2015: 29 · 2014: 20 · 2013: 18 · 2012: 30
FWCI: 16.18
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Clinical Infectious Diseases (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
DukeSpace (Duke University) (submittedVersion, cc-by-nc-nd)
Funders: National Institutes of Health (and K24)
Centers for Disease Control and Prevention
National Institute of Allergy and Infectious Diseases (K24AI072522, K23AI064613)
Topics: Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
Life Sciences › Immunology and Microbiology › Immunology › Immunodeficiency and Autoimmune Disorders
Health Sciences › Medicine › Oncology › Neutropenia and Cancer Infections
Keywords: invasive aspergillosis, mortality, hematopoietic stem cell transplantation, solid organ transplantation, prognostic factors, neutropenia, renal failure, liver dysfunction, methylprednisolone, amphotericin B, antifungal therapy, malnutrition, central nervous system disorders, race
MeSH terms: Adult, Antifungal Agents, Aspergillosis, Female, Humans, Male, Middle Aged, Postoperative Complications, Risk Factors, Cohort Studies, Organ Transplantation, Hematopoietic Stem Cell Transplantation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Factors Associated with Mortality in Transplant Patients with Invasive Aspergillosis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks